Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
Ticker SymbolZYBT
Company nameZhengye Biotechnology Holding Ltd
IPO dateJan 07, 2025
CEOMr. Songlin Song
Number of employees277
Security typeOrdinary Share
Fiscal year-endJan 07
AddressNo.1 Lianmeng Street, Jilin Economic &
CityJILIN
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code132101
Phone
Websitehttps://www.jlzybio.com./
Ticker SymbolZYBT
IPO dateJan 07, 2025
CEOMr. Songlin Song
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data